146 related articles for article (PubMed ID: 29264579)
21. DNMT3L inhibits hepatocellular carcinoma progression through DNA methylation of CDO1: insights from big data to basic research.
Yan X; Qi Y; Yao X; Zhou N; Ye X; Chen X
J Transl Med; 2024 Feb; 22(1):128. PubMed ID: 38308276
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
Kojima K; Nakamura T; Ooizumi Y; Igarashi K; Tanaka T; Yokoi K; Ishii S; Nishizawa N; Katoh H; Kosaka Y; Sato T; Watanabe M; Yamashita K
PLoS One; 2019; 14(1):e0211108. PubMed ID: 30677088
[TBL] [Abstract][Full Text] [Related]
23. Predictive Significance of Promoter DNA Methylation of
Kubota Y; Tanabe S; Azuma M; Horio K; Fujiyama Y; Soeno T; Furue Y; Wada T; Watanabe A; Ishido K; Katada C; Yamashita K; Koizumi W; Kusano C
J Gastric Cancer; 2021 Dec; 21(4):379-391. PubMed ID: 35079440
[TBL] [Abstract][Full Text] [Related]
24. Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study.
Yamashita K; Waraya M; Kim MS; Sidransky D; Katada N; Sato T; Nakamura T; Watanabe M
PLoS One; 2014; 9(12):e113546. PubMed ID: 25469504
[TBL] [Abstract][Full Text] [Related]
25. Cysteine dioxygenase type 1 (CDO1): Its functional role in physiological and pathophysiological processes.
Chen M; Zhu JY; Mu WJ; Guo L
Genes Dis; 2023 May; 10(3):877-890. PubMed ID: 37396540
[TBL] [Abstract][Full Text] [Related]
26. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the methylation of CpG islands in the
Maekawa H; Ito T; Orita H; Kushida T; Sakurada M; Sato K; Hulbert A; Brock MV
Oncol Lett; 2020 Mar; 19(3):2197-2204. PubMed ID: 32194717
[TBL] [Abstract][Full Text] [Related]
29. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
30. [The Role of Plasma CDO1 Methylation in the Early Diagnosis of Lung Cancer].
Wang P; Zhao H; Shi R; Liu X; Liu J; Ren F; Zhao Q; Zhang H; Li Y; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):314-320. PubMed ID: 32317090
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylated
Wang L; Dong L; Xu J; Guo L; Wang Y; Wan K; Jing W; Zhao L; Feng X; Zhang K; Guo M; Zou Y; Zhang L; Li Q
Front Oncol; 2022; 12():714663. PubMed ID: 35574348
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas.
Shaker M; Pascarelli KM; Plantinga MJ; Love MA; Lazar AJ; Ingram DR; von Mehren M; Lev D; Kipling D; Broccoli D
Biomark Cancer; 2014; 6():1-10. PubMed ID: 24741338
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
[TBL] [Abstract][Full Text] [Related]
34. The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.
Lv Z; Zou H; Peng K; Wang J; Ding Y; Li Y; Ren X; Wang F; Chang R; Liang L; Ding Y
PLoS One; 2013; 8(10):e77473. PubMed ID: 24147003
[TBL] [Abstract][Full Text] [Related]
35. DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.
Ushiku H; Yamashita K; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Katoh H; Watanabe M
Gastric Cancer; 2017 Sep; 20(5):784-792. PubMed ID: 28243814
[TBL] [Abstract][Full Text] [Related]
36. CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.
Dietrich D; Krispin M; Dietrich J; Fassbender A; Lewin J; Harbeck N; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Spyratos F; Foekens JA; Lesche R; Martens JW
BMC Cancer; 2010 Jun; 10():247. PubMed ID: 20515469
[TBL] [Abstract][Full Text] [Related]
37. Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer.
Kang YP; Torrente L; Falzone A; Elkins CM; Liu M; Asara JM; Dibble CC; DeNicola GM
Elife; 2019 May; 8():. PubMed ID: 31107239
[TBL] [Abstract][Full Text] [Related]
38. Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.
Ng PKS; Lau CPY; Lam EKY; Li SSK; Lui VWY; Yeo W; Ng YK; Lai PBS; Tsui SKW
Dig Dis Sci; 2018 Mar; 63(3):676-686. PubMed ID: 29353445
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
[TBL] [Abstract][Full Text] [Related]
40. Hypermethylated CDO1 and CELF4 in cytological specimens as triage strategy biomarkers in endometrial malignant lesions.
Qi B; Sun Y; Lv Y; Hu P; Ma Y; Gao W; Li S; Zhang X; Jin X; Liou Y; Liu P; Liu S
Front Oncol; 2023; 13():1289366. PubMed ID: 38107069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
